You searched for "innovation"
Tear Trough Filler Masterclass
Join us for a full-day course at our Harley Street clinic, where we discuss the lessons learned from unique expertise in treating thousands of patients. The course includes an in-depth understanding of the anatomy of the tear trough, patient and...Moorfields- Botulinum toxin: Is it injector error, side effects or complications July
This course is designed to improve clinical practice and improve the treatment, management and administration of botulinum toxin for blepharospasm, hemifacial spasm, bells palsy, gustatory lacrimation and entropion. OverviewDeveloped by Moorfields Adnexal Nurse Consultant Nicola Dunlop and delivered in conjunction...
An alternative to povidone-iodine for intravitreal injections?
While povidone-iodine (5% aqueous) preparations have historically been considered the most effective antimicrobial prophylaxis for ophthalmic procedures and have been adopted as routine for intravitreal injections, post-procedure pain is a commonly recognized adverse event of IVI and has typically been...
Lucentis for pseudophakic CMO
Pseudophakic cystoid macular oedema (CMO) develops angiographically in up to 20-30% after uneventful phacoemulsification. This study aimed to evaluate the potential efficacy and safety of intravitreal ranibizumab in patients with pseudophakic CMO after cataract surgery. Seven eyes were included in...
Incidence and outcomes of endophthalmitis with in-house compounded intravitreal bevacizumab injections
This multicentre study examining a five-year period from 2014 to 2018 evaluated the incidence rate and outcomes of endophthalmitis after intravitreal injection of in-house compounded bevacizumab. In-house compounded syringes were prepared in compounding pharmacy using sterile standard operating guidelines. All...
Review of chalazion treatment
Even though chalazion is a common eyelid lesion, there is lack of consensus on a treatment algorithm. Conservative management includes lid hygiene and warm compresses and, in some cases, steroid ointments for two to three weeks. More invasive options for...Alcon UK and Ireland announces launch of Clareon® PanOptix® Pro
- Sponsored Content - Alcon UK and Ireland announces launch of Clareon® PanOptix® Pro: Delivering a Light Experience Like Never Before in a Trifocal IOL1-7 , ¥ – now with less light scatter1,2,8-9 , * Clareon® PanOptix® Pro delivers: •...New genomic test saves Moorfields patient’s sight
Moorfields patient Ellie Irwin’s stubborn and debilitating eye inflammation was successfully treated as a result of a new metagenomic service identifying the cause of this as a rare infection. In 2019, Ellie first got symptoms of uveitis, a condition characterised...Non-arteritic anterior ischaemic optic neuropathy (NA-AION): a review
Ischaemic optic neuropathy (ION) is the commonest adult optic neuropathy encountered today in our ageing population, is a common cause of irreversible visual loss and is usually associated with underlying vascular disease. The condition is classified as follows: (a) Anterior...
